Global Biodefence October 31, 2020
The ReDIRECT Program is a new initiative from the Biomedical Advanced Research and Development Authority (BARDA) which aims to identify existing, commonly available therapeutics that can be used to save lives during a chemical emergency. The program is focused on repurposing therapeutics against any of the following agents: Pulmonary Agents, Opioids, Vesicants, Blood/Metabolic Agents, Nerve Agents and Organophosphorus (OP) Pesticides, Computational approaches to identify candidates for drug repurposing. Under the EZ BAA Area of Interest (AOI), BARDA will review concise abstract submissions for funding development that repurposes easily accessible therapeutics as medical countermeasures. The effort is a collaboration of BARDA’s Division of Research, Innovation, and Ventures (DRIVe) and the Chemical, Biological, Radiological and Nuclear (CBRN) Division…read more.